Undertreatment of pain

Last updated

Undertreatment of pain is the absence of pain management therapy for a person in pain when treatment is indicated.[ citation needed ]

Contents

Consensus in evidence-based medicine and the recommendations of medical specialty organizations establish the guidelines which determine the treatment for pain which health care providers ought to offer. [1] For various social reasons, persons in pain may not seek or may not be able to access treatment for their pain. [1] At the same time, health care providers may not provide the treatment which authorities recommend. [1]

Classification

When pain is a symptom of a disease, then treatment may focus on addressing the cause of the disease. [2] Because of the hope that treatment which ends the disease would eliminate the pain, sometimes pain management is not recognized as a priority in favor of efforts to address an underlying cause of the pain. [2]

In other cases, the pain itself might need its own treatment plan. [2] Palliative care could be used to address the pain as its own priority. [2] Palliative care might be used either with or alongside any treatment for an underlying condition. [2]

Signs and symptoms

Some organizations advise that health care providers treat pain whenever it is present. The perspective is that when a person complains of serious pain, then that person is in need of treatment.

Various publications offer guidance on recognizing pain and advising when a person with pain needs additional treatment. [3] [4] [5] [6]

Causes

This phenomenon can be associated with a multitude of causes. Firstly, the biomedical model of disease, focused on pathophysiology rather than quality of life, reinforces entrenched attitudes that marginalize pain management as a priority. [7] Other reasons may have to do with inadequate training, personal biases or fear of prescription drug abuse. For example, physicians may fear of being accused of overprescribing (see for instance the case of Dr William Hurwitz), despite the relative rarity of prosecutions, or physicians' poor understanding of the health risks attached to opioid prescription. [8] A complicated history of politics also influences practices in the treatment of pain. [9] This includes cultural, societal, religious, and political attitudes. These factors often disadvantage certain groups, such as the above populations, in seeking treatment for pain.

Undertreatment of pain may also be caused by biases among healthcare practitioners. [10]

Affected populations

Undertreatment of pain is common and is experienced by all age groups, from neonates to the elderly. [11] [12] In September 2008, the World Health Organization (WHO) estimated that approximately 80 percent of the world population has either no or insufficient access to treatment for moderate to severe pain. [13] Every year, tens of millions of people globally, including around four million cancer patients and 0.8 million HIV/AIDS patients, suffer from lack of pain relief as part of their end-of-life treatment. [14] Yet the medications to treat pain are cheap, safe, effective, and generally straightforward to administer, and international law obliges countries to make adequate pain medications available. [14]

In addition, there are multiple demographics, namely elders, non-white racial minorities, and women, which suffer from undertreatment at disproportionate rates relative to their younger, non-Hispanic white male peers. [15] [16] [17]

Pain, particularly chronic pain, is understood via a constellation of factors, specifically pathopsychology, cognitive, affective, behavioral and sociocultural factors.[ citation needed ] As such, the adequate treatment of pain requires a multidisciplinary approach that accounts for how chronic pain is experienced differently among patients of differing cultures and ethnicities.[ citation needed ]

Some pain patients are made invisible through the limited representation of people of color in clinical research, the marketing of analgesics, and biases among healthcare practitioners leading their pain to be ignored. [18] While decades of pain research have neither produced a clear and consistent pattern of sex difference in human pain tolerance, [19] nor substantiated "fantastical" claims about racialized pain tolerance, [18] biases within the medical sphere persist in ways which disenfranchise minoritized patients causing the undertreatment of pain.

Age

Undertreatment in the elderly can be due to a variety of reasons including the misconception that pain is a normal part of aging, therefore it is unrealistic to expect older adults to be pain free. Other misconceptions surrounding pain and older adults are that older adults have decreased pain sensitivity, especially if they have a cognitive dysfunction such as dementia and that opioids should not be administered to older adults as they are too dangerous. However, with appropriate assessment and careful administration and monitoring older adults can have to same level of pain management as any other population of care. [15] [20]

However, as a result of two recent cases in California where physicians who failed to provide adequate pain relief were successfully sued for elder abuse, the North American medical and health care communities appear to be undergoing a shift in perspective. The California Medical Board publicly reprimanded the physician in the second case; the federal Center for Medicare and Medicaid Services has declared a willingness to charge with fraud health care providers who accept payment for providing adequate pain relief while failing to do so; and clinical practice guidelines and standards are evolving into clear, unambiguous statements on acceptable pain management, so health care providers, in California at least, can no longer avoid culpability by claiming that poor or no pain relief meets community standards.

Race

Literature examining the medical field indicates disparities in pain care for racial and ethnic minorities. [16] Compared to Caucasian patients, African American and Hispanic patients are particularly at risk for being undertreated for pain. [16] There are a variety of conditions for which African Americans and other racial and ethnic minorities experience continuous undertreatment, including cancer pain, acute postoperative pain, chest pain, acute pain, and chronic low back pain. [16] Research demonstrates that even when controlling for age, gender, and pain intensity, racial and ethnic minorities are frequently subjected to insufficient treatment for acute and chronic pain when compared to non-Hispanic whites. [21] A study examining over 1300 non-minority and minority patients discovered that those at facilities with principally minority patients were three times more likely to be undermedicated than patients treated in non-minority facilities. Furthermore, a follow-up study that investigated pain treatment in minority patients with recurrent or metastatic cancer found that 74% of Latinx and 59% of African American patients experiencing pain were not given the adequate analgesics. [22] Minority patients, when compared to non-minority patients, were not as likely to be appropriately evaluated for their pain and reported less pain relief. [22] Although the prescription of opioid analgesics in response to pain-related visits grew from 1993 to 2005, disparities in prescribing to racial and ethnic minorities persisted. White patients experiencing pain were considerably more likely to be prescribed an opioid analgesic when compared to Black, Hispanic or Asian patients. Specifically, 40% of white patients were prescribed opioid analgesics in 2005, while only 32% of nonwhite patients experiencing pain were prescribed them. [22]

Sickle cell disease

Around 100,000 Americans are affected by sickle cell disease (SCD), the majority of whom are of African or Hispanic descent, and half of the adults with SCD don't survive past their early-40s. [23] A characteristic feature of SCD is pain crises, or episodes of pain, which can vary in frequency and severity among individuals; sickle cell pain can be a sign of a lack of oxygen delivery to vital organs (vaso-occlusive crisis), which can lead to organ damage and death. [23] [24] Pain itself can exacerbate the severity of the disease as it causes blood vessels to constrict and further prevents proper oxygen circulation in the body. [23] [25]

Disparities in access to treatment and quality of care affect those with SCD, particularly treatment for pain relief. [25] Sickle cell patients often face delayed care in emergency rooms, with patients at one hospital found to have 60% longer wait times to get pain medication compared to those with less severe symptoms of pain. [23] Inadequate training of doctors and nurses to treat SCD is another contributing factor to undertreated pain in this population of patients: medical schools often offer very little sickle cell education, resulting in physicians who don't know how to properly care for sickle cell patients. [23] [26] In a survey of 3,000 family physicians, only 20% claimed they felt confident in treating the disease, meaning many cannot provide appropriate routine care for individuals with SCD. [23] Furthermore, access to specialists and SCD treatment centers is difficult for many patients. Health insurance policies may prevent patients from seeing the specialists equipped to deliver quality care for SCD, and hematologists and treatment centers who specialize in SCD are scarce in general, adding a further barrier for patients to find care within an accessible distance. [23] [27]

Racial stereotyping and the opioid crisis have made physicians more hesitant to give opioid medication to sickle cell patients presenting with pain. [23] [26] Those in acute sickle crises are often seen as drug seeking because many doctors are trained to look out for the following behaviors: asking for a specific opioid medication, returning many times for the same issue, having complaints that are "out of proportion," and seeking treatment at a hospital. [23] Sickle cell patients often are very familiar with their treatment plans and which medications work for them; yet, doctors are also often suspicious of patients who know too much about the pain medications they need. [23] Furthermore, SCD patients usually require higher doses as they build tolerance towards the drug, making doctors who aren't familiar with the case even more unlikely to trust the patient and provide necessary care. [23] Overall, however, there is not a lot of evidence showing particularly high rates of addiction among sickle cell patients: one study found stable opioid use among SCD patients over time while rates of use and addiction have increased in America. [27] Nevertheless, practices have been put in place to prevent opioid dependence among sickle cell patients: rather than giving injections of hydromorphone, many hospitals have instituted a new protocol that delivers hydromorphone in a diluted form using IV drips; the slower medication delivery leaves SCD patients experiencing severe crises still in pain. [27]

Hydroxyurea, originally to treat cancer, is an oral drug that can also effectively and safely reduce pain crises in sickle cell patients by increasing quantities of normal red blood cells, yet it's often underprescribed and underutilized; reasons include barriers to obtaining refills, need for management and follow up visits, and side effects, including reduction in white blood cells. [23] [25] Fewer than 25% of adult patients who need hydroxyurea to prevent pain crises actually are able to receive it outside the hospital. [23] [25]

Gender

History and background

There are disparities in the quality of healthcare between sexes and genders, and because pain is one of the most common reasons for people to seek healthcare, accessibility dictates whether one receives necessary treatment. Research shows that there are biological differences in the experience of pain both along biological sex lines and along gender identity lines. Under treatment of pain correlates to socially constructed gendered expectations built throughout centuries. The Yellow Wallpaper is the most famous narrative of a woman being treated for hysteria, an ethically problematic diagnosis that was the precursor or introduction to the concept of mental health and its physical symptoms. It is an example of how femininity is medicalized to perpetuate gendered identities.This novel evokes the concept of hysteria, a term which was used to refer to women's mental health issues in which they were assigned the narrative of being dramatic, exaggerative, and emotional. There is also evidence to support that social expectations about the expression of pain can dictate patient and doctor responses, linking the treatment of pain to social stereotypes. [28] The way humans are socialized explains why women are assumed to be dramatic because men are taught to silence their pain and their capacity to express themselves has been muted. [29] The University of Gothenburg conducted a study which found that women's pain is evaluated on comparison to men due to the gender-norms which label men as unemotional and women as "hysteric". [29] The consequences of this perception is the assumption that women are either imagining or exaggerating their pain, so that they don't receive the care they need which is a sentiment that still exists today and plays into why women are undertreated for their pain.

Treatment disparities

Research shows that women are much more likely than men to be prescribed sedatives instead of pain medication. [30] Doctor Calderone found that male patients that underwent coronary artery bypass grafts received narcotics more readily than females, and the female patients received sedative agents more often, hinting at anxiety being the root of their problems instead of pain. [31] Additionally, women are 13 to 25 percent less likely than men to receive strong "opioid" pain medication. [29] Even today women are more likely than men to be gaslit that the pain they are experiencing is all in their head. [32] Women who were emitted to the emergency room with severe stomach pain had to wait 33% longer than men with the same symptoms. [32] Females are also expected to endure more pain as a result of their biological processes, like giving birth and the effects of their menstrual cycle, in addition to the pain that comes with injury, illness, disease, that men experience aside from biological processes. [17] The female experience of having to differentiate between normal biological pain and outside pain (illness, disease, etc.) is an experience unique to women which is why they are most often gaslit into believing the pain from injury, illness or disease comes from the processes and the pain they are expected to tolerated associated with birthing and menstrual cycles. [17]

Under-representation of women in studies

Medical knowledge is collected through studies on biologically male bodies which raises concerns of applicability of this knowledge to biologically female bodies. Historically, women have been underrepresented in clinical studies, meaning that their experience of pain and their reaction to various medications is less understood. [33]

Chronic pain

Additionally, chronic pain, and conditions of chronic pain, are more common in women, but the rates of chronic pain and the differences in experience between men and women are not well documented. [34] Chronic pain in women may also be attributed to reproductive issues like polycystic ovary syndrome, endometriosis, menopause, dysmenorrhea, even when these are not related to the pain women are experiencing. [8]

Epidemiology

United States

In the U.S., historical and ongoing racism against nonwhites has led to the undertreatment of pain for minorities. Research review by the National Academy of Medicine has recorded persistent qualitative discrepancies between the medical care provided to racial minorities. In its publication Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare, researchers cite cultural barriers, distrust of the healthcare system by racial minorities, and racial stereotyping. In the case of cultural barriers, physicians and their patients may lack the tools to communicate effectively because of language barriers and other differences. [35] Many minority individuals may not trust their doctors due to past and current unethical medical practices, such as experiments performed on slaves, the Tuskegee Syphilis Study, and the forced sterilization of Native American women, African Americans, and potentially, current immigrants in ICE detention centers. [36] [37] They therefore avoid care or do not fully participate in treatment plans. [35] Furthermore, healthcare providers, who are typically white, may also empathize more with patients of their own race than with others.

Europe

Research conducted in Europe for the Journal of Pain & Palliative Care Pharmacotherapy has found that undertreatment of chronic pain in patients is widespread and is tied to legislative controls that regulate opioid prescription, which in turn creates fear of prescribing in providers. Patients are also hesitant to take opioids due to fear of dependency. [38]

India

A case study published in the Journal of Pain Research revealed that in India, standardized pain management plans, which are designed to prevent pain mismanagement, are often not followed by doctors. Many physicians cited fear of addiction or dependence as a reason for their hesitancy to prescribe opioids, even when indicated. In addition, they found that several other cultural factors influenced the patient's adherence to pain plans. These included fear of opioid dependence, fear of questioning authority, and the cultural belief that suffering is a part of illness and therefore should be faced with stoicism. [39]

The article also noted that similarly to the United States, several specific populations were found to have more issues with undertreatment of pain, including children, the elderly, and those with renal or hepatic dysfunction. Concerns with the elderly are often due to the prevalence of multiple comorbidities that make pain difficult to manage. Children often have communication barriers and neonates may be assumed not to feel pain.  Many drugs are activated and excreted through the liver or kidney, so when there is hepatic or renal illness, pain medication dosing needs to be adjusted in a way that isn't always standardized. [39]

Latin America

Similar to the United States and India, fear of prescribing opioids is a main reason cited for ineffective pain management in Latin America. A study in Pain Management notes that there is an overuse of nonopioid analgesics in Latin America due to this hesitancy that can be traced back to lack of training of physicians and health care providers. Other barriers to access include limited access to healthcare. Undertreatment of pain is widespread due to both the lack of access to opioids, which results in moderate to severe pain being managed with non-opioid analgesics that are not as effective, and fear of prescribing opioids when available. [40] However there is also evidence that the reluctance to use opioids in latin america served as a protective factor against the opioid crisis [41]

Consequences

Health care and pharmaceutical drugs such as pain medications are costly Healthcare costs.jpg
Health care and pharmaceutical drugs such as pain medications are costly

Inadequate pain management can leave several lasting impacts on individuals, such as a decreased quality of life (QOL). [26] Higher pain severity has been found to be associated with lower self-reported evaluations of mental and physical wellness, negatively affecting a wide range of QOL components, including sleep, mood, mobility and physical functioning, sexual relationships, and social life. [26] Individuals with chronic pain are more likely to have psychiatric illnesses, such as depression, anxiety, and post-traumatic stress disorder. [42]

Lack of postsurgical pain relief leads to higher healthcare costs as recovery time and hospital stays are prolonged. [26] Undertreatment of symptoms of pain in sickle cell patients, for instance, can give rise to millions of dollars per year directed towards more frequent emergency room visits, hospitalizations, as well as the costly effects of lost work productivity. [24] The timely and appropriate treatment of pain, thus, can reduce economic burdens and, because pain is one of the primary reasons for hospital readmissions, significantly lower the prevalence of patients who need to return for more care. [26]

Undertreated acute pain may also have more lasting physiological consequences and further contribute to healthcare spending that's avoidable. Severe pain can interfere with a patient's respiratory and cardiovascular physiology with increased risks of respiratory infection, myocardial ischemia, infarct or cardiac failure, and thromboembolic disease, impeding the patient's ability to recover and be discharged. [42] Studies on patients hospitalized for issues ranging from childbirth to burn injuries to breast surgery to other serious illnesses have also all pointed to more intense acute pain levels being a risk factor for the development of chronic pain; the evidence indicates that insufficient treatment of acute pain doesn't only have temporary consequences for patients, but potentially also a decreased QOL for the rest of the patient's life. [26] Acute pain, without appropriate management, can lead to chronic pain through immunological and neurological changes. [42]

Prevention and screening

Current strategies for improvement in pain management include framing it as an ethical issue; promoting pain management as a legal right; providing constitutional guarantees and statutory regulations that span negligence law, criminal law, and elder abuse; defining pain management as a fundamental human right; categorizing failure to provide pain management as professional misconduct, and issuing guidelines and standards of practice by professional bodies. [7]

History

In 1961 the Single Convention on Narcotic Drugs established that certain drugs are "indispensable for the relief of pain and suffering" and that states should make them available to people who need them. [1]

In 2009, a WHO report noted that accessing treatment for pain was difficult for many people in many places in the world for a range of reasons. [1] [43]

In 2010 the Commission on Narcotic Drugs and adopted a resolution on access to pain treatments. [1] Also in 2010 the United Nations Office on Drugs and Crime published a feature explaining the problem of lack of access to pain treatment and expressing interest in the topic. [1] In 2011 the International Narcotics Control Board published a supplement to its annual report which highlighted the issue as a concern to be addressed. [1]

See also

Related Research Articles

<span class="mw-page-title-main">Pain</span> Type of distressing feeling

Pain is a distressing feeling often caused by intense or damaging stimuli. The International Association for the Study of Pain defines pain as "an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage."

Chronic pain or chronic pain syndrome is a type of pain that is also known by other titles such as gradual burning pain, electrical pain, throbbing pain, and nauseating pain. This type of pain is sometimes confused with acute pain and can last from three months to several years; Various diagnostic manuals such as DSM-5 and ICD-11 have proposed several definitions of chronic pain, but the accepted definition is that it is "pain that lasts longer than the expected period of recovery."

<span class="mw-page-title-main">Back pain</span> Area of body discomfort

Back pain is pain felt in the back. It may be classified as neck pain (cervical), middle back pain (thoracic), lower back pain (lumbar) or coccydynia based on the segment affected. The lumbar area is the most common area affected. An episode of back pain may be acute, subacute or chronic depending on the duration. The pain may be characterized as a dull ache, shooting or piercing pain or a burning sensation. Discomfort can radiate to the arms and hands as well as the legs or feet, and may include numbness or weakness in the legs and arms.

Palliative care is an interdisciplinary medical caregiving approach aimed at optimizing quality of life and mitigating suffering among people with serious, complex, and often terminal illnesses. Within the published literature, many definitions of palliative care exist. The World Health Organization (WHO) describes palliative care as "an approach that improves the quality of life of patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain, illnesses including other problems whether physical, psychosocial, and spiritual". In the past, palliative care was a disease specific approach, but today the WHO takes a broader patient-centered approach that suggests that the principles of palliative care should be applied as early as possible to any chronic and ultimately fatal illness. This shift was important because if a disease-oriented approach is followed, the needs and preferences of the patient are not fully met and aspects of care, such as pain, quality of life, and social support, as well as spiritual and emotional needs, fail to be addressed. Rather, a patient-centered model prioritizes relief of suffering and tailors care to increase the quality of life for terminally ill patients.

<span class="mw-page-title-main">Pain management</span> Interdisciplinary approach for easing pain

Pain management is an aspect of medicine and health care involving relief of pain in various dimensions, from acute and simple to chronic and challenging. Most physicians and other health professionals provide some pain control in the normal course of their practice, and for the more complex instances of pain, they also call on additional help from a specific medical specialty devoted to pain, which is called pain medicine.

<span class="mw-page-title-main">Opioid</span> Psychoactive chemical

Opioids are a class of drugs that derive from, or mimic, natural substances found in the opium poppy plant. Opioids work in the brain to produce a variety of effects, including pain relief. As a class of substances, they act on opioid receptors to produce morphine-like effects.

Terminal illness or end-stage disease is a disease that cannot be cured or adequately treated and is expected to result in the death of the patient. This term is more commonly used for progressive diseases such as cancer, dementia or advanced heart disease than for injury. In popular use, it indicates a disease that will progress until death with near absolute certainty, regardless of treatment. A patient who has such an illness may be referred to as a terminal patient, terminally ill or simply as being terminal. There is no standardized life expectancy for a patient to be considered terminal, although it is generally months or less. Life expectancy for terminal patients is a rough estimate given by the physician based on previous data and does not always reflect true longevity. An illness which is lifelong but not fatal is a chronic condition.

<span class="mw-page-title-main">Opioid use disorder</span> Medical condition

Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are important components of opioid use disorder.

Health equity arises from access to the social determinants of health, specifically from wealth, power and prestige. Individuals who have consistently been deprived of these three determinants are significantly disadvantaged from health inequities, and face worse health outcomes than those who are able to access certain resources. It is not equity to simply provide every individual with the same resources; that would be equality. In order to achieve health equity, resources must be allocated based on an individual need-based principle.

<span class="mw-page-title-main">Primary care physician</span> US term for medical professional providing first-line care

A primary care physician (PCP) is a physician who provides both the first contact for a person with an undiagnosed health concern as well as continuing care of varied medical conditions, not limited by cause, organ system, or diagnosis. The term is primarily used in the United States. In the past, the equivalent term was 'general practitioner' in the US; however in the United Kingdom and other countries the term general practitioner is still used. With the advent of nurses as PCPs, the term PCP has also been expanded to denote primary care providers.

A chronic condition is a health condition or disease that is persistent or otherwise long-lasting in its effects or a disease that comes with time. The term chronic is often applied when the course of the disease lasts for more than three months. Common chronic diseases include diabetes, functional gastrointestinal disorder, eczema, arthritis, asthma, chronic obstructive pulmonary disease, autoimmune diseases, genetic disorders and some viral diseases such as hepatitis C and acquired immunodeficiency syndrome. An illness which is lifelong because it ends in death is a terminal illness. It is possible and not unexpected for an illness to change in definition from terminal to chronic. Diabetes and HIV for example were once terminal yet are now considered chronic due to the availability of insulin for diabetics and daily drug treatment for individuals with HIV which allow these individuals to live while managing symptoms.

<span class="mw-page-title-main">Lubiprostone</span> Medication used for constipation

Lubiprostone, sold under the brand name Amitiza among others, is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. The drug is owned by Mallinckrodt and is marketed by Takeda Pharmaceutical Company.

End-of-life care (EOLC) is health care provided in the time leading up to a person's death. End-of-life care can be provided in the hours, days, or months before a person dies and encompasses care and support for a person's mental and emotional needs, physical comfort, spiritual needs, and practical tasks.

An equianalgesic chart is a conversion chart that lists equivalent doses of analgesics. Equianalgesic charts are used for calculation of an equivalent dose between different analgesics. Tables of this general type are also available for NSAIDs, benzodiazepines, depressants, stimulants, anticholinergics and others.

<span class="mw-page-title-main">Sickle cell disease</span> Group of genetic blood disorders

Sickle cell disease (SCD), also simply called sickle cell, is a group of hemoglobin-related blood disorders typically inherited. The most common type is known as sickle cell anemia. It results in an abnormality in the oxygen-carrying protein haemoglobin found in red blood cells. This leads to a rigid, sickle-like shape under certain circumstances. Problems in sickle cell disease typically begin around 5 to 6 months of age. A number of health problems may develop, such as attacks of pain in joints, anemia, swelling in the hands and feet, bacterial infections, dizziness and stroke. Long-term pain may develop as people get older. The average life expectancy in the developed world is 40 to 60 years. It often gets worse within age. All the major organs are affected by sickle cell disease. The liver, heart, kidneys, gallbladder, eyes, bones, and joints also can suffer damage from the abnormal functions of the sickle cells, and their inability to flow through the small blood vessels correctly.

<span class="mw-page-title-main">Cancer treatment</span> Overview of various treatment possibilities for cancer

Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, and PARP inhibitors such as olaparib. Other therapies include hyperthermia, immunotherapy, photodynamic therapy, and stem-cell therapy. Most commonly cancer treatment involves a series of separate therapies such as chemotherapy before surgery. Angiogenesis inhibitors are sometimes used to enhance the effects of immunotherapies.

<span class="mw-page-title-main">Gender bias in medical diagnosis</span> Concept in medical & psychological diagnoses

Gender-biased diagnosing is the idea that medical and psychological diagnosis are influenced by the patient's gender. Several studies have found evidence of differential diagnosis for patients with similar ailments but of different sexes. Female patients face discrimination through the denial of treatment or miss-classification of diagnosis as a result of not being taken seriously due to stereotypes and gender bias. According to traditional medical studies, most of these medical studies were done on men thus overlooking many issues that were related to women's health. This topic alone sparked controversy and questions about the medical standard of our time. Popular media has illuminated the issue of gender bias in recent years. Research that was done on diseases that affected women more were less funded than those diseases that affected men and women equally.

Pain in cancer may arise from a tumor compressing or infiltrating nearby body parts; from treatments and diagnostic procedures; or from skin, nerve and other changes caused by a hormone imbalance or immune response. Most chronic (long-lasting) pain is caused by the illness and most acute (short-term) pain is caused by treatment or diagnostic procedures. However, radiotherapy, surgery and chemotherapy may produce painful conditions that persist long after treatment has ended.

<span class="mw-page-title-main">Opioid epidemic</span> Deaths due to abuse of opioid drugs

The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs called opiates/opioids since the 1990s. It includes the significant medical, social, psychological, demographic and economic consequences of the medical, non-medical, and recreational abuse of these medications.

<span class="mw-page-title-main">Vence L. Bonham Jr.</span>

Vence L. Bonham Jr. is an American lawyer who is the acting Deputy Director of the National Human Genome Research Institute (NHGRI) of the U. S. National Institutes of Health, and is the leader of the NHGRI Health Disparities Unit. His research focuses on social determinants of health, particularly with regard to the social implications of new genomic knowledge and technologies.

References

  1. 1 2 3 4 5 6 7 8 Human Rights Watch (2 June 2011), Global State of Pain Treatment: Access to Medicines and Palliative Care, Human Rights Watch, retrieved 28 July 2016
  2. 1 2 3 4 5 King NB, Fraser V (2013). "Untreated pain, narcotics regulation, and global health ideologies". PLOS Medicine. 10 (4): e1001411. doi: 10.1371/journal.pmed.1001411 . PMC   3614505 . PMID   23565063.
  3. ↑ International Pain Summit of the International Association for the Study of Pain (24 March 2011). "Declaration of Montréal: declaration that access to pain management is a fundamental human right". Journal of Pain & Palliative Care Pharmacotherapy. 25 (1): 29–31. doi:10.3109/15360288.2010.547560. PMID   21426215. S2CID   33839459.
  4. ↑ Fishman SM (July 2007). "Recognizing pain management as a human right: a first step". Anesthesia and Analgesia. 105 (1): 8–9. CiteSeerX   10.1.1.558.6197 . doi:10.1213/01.ane.0000267526.37663.41. PMID   17578943.
  5. ↑ Lipman AG (17 August 2009). "Pain as a Human Right". Journal of Pain & Palliative Care Pharmacotherapy. 19 (3): 85–100. doi:10.1080/j354v19n03_16. S2CID   71616309.
  6. ↑ Lohman D, Schleifer R, Amon JJ (January 2010). "Access to pain treatment as a human right". BMC Medicine. 8 (1): 8. doi: 10.1186/1741-7015-8-8 . PMC   2823656 . PMID   20089155.
  7. 1 2 Brennan F., Carr D.B., Cousins M., Pain Management: A Fundamental Human Right, Pain Medicine, V. 105, N. 1, July 2007.
  8. 1 2
  9. ↑ Anderson T (August 2010). "The politics of pain". BMJ. 341 (aug11 2): c3800. doi:10.1136/bmj.c3800. PMID   20702554. S2CID   39650773.
  10. ↑ Hampton SB, Cavalier J, Langford R (December 2015). "The Influence of Race and Gender on Pain Management: A Systematic Literature Review". Pain Management Nursing. 16 (6): 968–77. doi: 10.1016/j.pmn.2015.06.009 . PMID   26697821.
  11. ↑
  12. ↑
  13. ↑ Medicines Access and Rational Use (February 2009), Access to Controlled Medications Programme - Improving access to medications controlled under international drug conventions (PDF), Department of Essential Medicines and Pharmaceutical Policies Health Systems and Services, World Health Organization, retrieved 28 July 2016
  14. 1 2 Human Rights Watch, "Please, do not make us suffer any more..." Access to Pain Treatment as a Human Right, March 2009
  15. 1 2 Blomqvist K (March 2003). "Older people in persistent pain: nursing and paramedical staff perceptions and pain management". Journal of Advanced Nursing. 41 (6): 575–84. doi:10.1046/j.1365-2648.2003.02569.x. PMID   12622866. S2CID   26639295.
  16. 1 2 3 4 Green CR, Anderson KO, Baker TA, Campbell LC, Decker S, Fillingim RB, et al. (September 2003). "The unequal burden of pain: confronting racial and ethnic disparities in pain". Pain Medicine. 4 (3): 277–94. doi: 10.1046/j.1526-4637.2003.03034.x . hdl: 2027.42/73822 . PMID   12974827.
  17. 1 2 3
  18. 1 2 Pryma, Jane (2017-09-01). "Pain, citizenship, and invisibility: A response to Joanna Kempner". Social Science & Medicine. 189: 155–157. doi:10.1016/j.socscimed.2017.07.022. ISSN   0277-9536. PMID   28781095.
  19. ↑ Racine, Melanie; Tousignant-Laflamme, Yannick; Kloda, Lorie; Dion, Dominique; Dupuis, Gilles; Choinière, Manon (November 22, 2011). "A systematic literature review of 10 years of research on sex/gender and experimental pain perception – Part 1: Are there really differences between women and men?" (PDF). International Association for the Study of Pain. 153: 602–618.
  20. ↑ Coker E, Papaioannou A, Kaasalainen S, Dolovich L, Turpie I, Taniguchi A (August 2010). "Nurses' perceived barriers to optimal pain management in older adults on acute medical units". Applied Nursing Research. 23 (3): 139–46. doi:10.1016/j.apnr.2008.07.003. PMID   20643323.
  21. ↑ Mossey JM (July 2011). "Defining racial and ethnic disparities in pain management". Clinical Orthopaedics and Related Research. 469 (7): 1859–70. doi:10.1007/s11999-011-1770-9. PMC   3111792 . PMID   21249483.
  22. 1 2 3 Anderson KO, Green CR, Payne R (December 2009). "Racial and ethnic disparities in pain: causes and consequences of unequal care". The Journal of Pain. 10 (12): 1187–204. doi: 10.1016/j.jpain.2009.10.002 . PMID   19944378.
  23. 1 2 3 4 5 6 7 8 9 10 11 12 13 "In excruciating pain, sickle cell patients are shunted aside". STAT. 2017-09-18. Retrieved 2021-04-04.
  24. 1 2 Taylor LE, Stotts NA, Humphreys J, Treadwell MJ, Miaskowski C (September 2010). "A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease". Journal of Pain and Symptom Management. 40 (3): 416–35. doi: 10.1016/j.jpainsymman.2009.12.027 . PMC   2989986 . PMID   20656451.
  25. 1 2 3 4 Lee L, Smith-Whitley K, Banks S, Puckrein G (2019-11-01). "Reducing Health Care Disparities in Sickle Cell Disease: A Review". Public Health Reports. 134 (6): 599–607. doi:10.1177/0033354919881438. PMC   6832089 . PMID   31600481.
  26. 1 2 3 4 5 6 7 Sinatra R (December 2010). "Causes and consequences of inadequate management of acute pain". Pain Medicine. 11 (12): 1859–71. doi: 10.1111/j.1526-4637.2010.00983.x . PMID   21040438.
  27. 1 2 3 "Effort To Control Opioids In An ER Leaves Some Sickle Cell Patients In Pain". NPR.org. Retrieved 2021-04-04.
  28. ↑ Tsui, Siu Lun; Chen, Phoon Ping; Ng, Kwok Fu Jacobus (2010). Pain medicine: a multidisciplinary approach. ISBN   978-988-220-623-6. OCLC   709890951.
  29. 1 2 3 "The Gender Gap In Pain". Junkee. 2018-12-30. Retrieved 2022-05-01.
  30. ↑ Kiesel, Laura (2017-10-09). "Women and pain: Disparities in experience and treatment". Harvard Health. Retrieved 2022-05-01.
  31. ↑ Hoffmann, Diane E.; Tarzian, Anita J. (2001). "The Girl Who Cried Pain: A Bias against Women in the Treatment of Pain". Journal of Law, Medicine & Ethics. 29 (1): 13–27. doi:10.1111/j.1748-720x.2001.tb00037.x. ISSN   1073-1105. PMID   11521267. S2CID   219952180.
  32. 1 2 "Gaslighting in women's health: when doctors dismiss symptoms | Northwell Health". www.northwell.edu. Retrieved 2022-05-01.
  33. ↑ Liu; Mager, Katherine A.; Natalie A. Dipietro (2016). ""Women's involvement in clinical trials: historical perspective and future implications"". Pharmacy Practice. 14 (1): 708. doi:10.18549/PharmPract.2016.01.708. PMC   4800017 . PMID   27011778.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  34. ↑ Hampton, Sharon B.; Cavalier, James; Langford, Rae (December 2015). "The Influence of Race and Gender on Pain Management: A Systematic Literature Review". Pain Management Nursing. 16 (6): 968–977. doi: 10.1016/j.pmn.2015.06.009 . ISSN   1524-9042. PMID   26697821.
  35. 1 2 Read "Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care" at NAP.edu. 2003. doi:10.17226/12875. ISBN   978-0-309-21582-4. PMID   25032386. S2CID   34750106.
  36. ↑ "Black Genocide | American Experience | PBS". www.pbs.org. Retrieved 2020-10-17.
  37. ↑ "ICE, A Whistleblower And Forced Sterilization : 1A". NPR.org. Retrieved 2020-10-17.
  38. ↑ Galvez R (2009-11-30). "Variable use of opioid pharmacotherapy for chronic noncancer pain in Europe: causes and consequences". Journal of Pain & Palliative Care Pharmacotherapy. 23 (4): 346–56. doi:10.3109/15360280903323665. PMID   19947833. S2CID   11562009.
  39. 1 2 Dureja GP, Iyer RN, Das G, Ahdal J, Narang P (2017-03-29). "Evidence and consensus recommendations for the pharmacological management of pain in India". Journal of Pain Research. 10: 709–736. doi: 10.2147/jpr.s128655 . PMC   5386610 . PMID   28435313.
  40. ↑ García CA, Santos Garcia JB, Rosario Berenguel Cook MD, Colimon F, Flores Cantisani JA, Guerrero C, et al. (May 2018). "Undertreatment of pain and low use of opioids in Latin America". Pain Management. 8 (3): 181–196. doi:10.2217/pmt-2017-0043. PMID   29774774.
  41. ↑ Preissner, Saskia; Siramshetty, Vishal B.; Dunkel, Mathias; Steinborn, Paul; Luft, Friedrich C.; Preissner, Robert (2019-02-26). "Pain-Prescription Differences - An Analysis of 500,000 Discharge Summaries". Current Drug Research Reviews. 11 (1): 58–66. doi:10.2174/1874473711666180911091846. ISSN   2589-9775 – via eurekaselect.
  42. 1 2 3 King NB, Fraser V (2013-04-02). "Untreated pain, narcotics regulation, and global health ideologies". PLOS Medicine. 10 (4): e1001411. doi: 10.1371/journal.pmed.1001411 . PMC   3614505 . PMID   23565063.
  43. ↑ Medicines Access and Rational Use (February 2009), Access to Controlled Medications Programme - Improving access to medications controlled under international drug conventions (PDF), Department of Essential Medicines and Pharmaceutical Policies Health Systems and Services, World Health Organization, retrieved 28 July 2016
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.